Genomictree Inc. (KOSDAQ:228760)

Genomictree Revenue

Genomictree had revenue of 381.61M KRW in the quarter ending March 31, 2026, with 20.58% growth. This brings the company's revenue in the last twelve months to 3.83B, up 59.78% year-over-year. In the year 2025, Genomictree had annual revenue of 3.76B with 59.17% growth.

• Revenue (ttm): 3.83B
• Revenue Growth: +59.78%
• P/S Ratio: 77.43
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 296.20B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.76B	1.40B	59.17%
Dec 31, 2024	2.36B	-1.06B	-30.89%
Dec 31, 2023	3.42B	-26.45B	-88.56%
Dec 31, 2022	29.87B	24.73B	481.09%
Dec 31, 2021	5.14B	3.90B	314.87%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 9, 2026

Data Sources Report a data error